Agenda

Targeting the PI3 Kinase Pathway in HR+ Metastatic Breast Cancer

Karthik V. Giridhar, MD

‍

Novel Antiestrogen Agents for HR+ Metastatic Breast Cancer

Michael Danso, MD

‍

Key Updates Related to Antibody Drug Conjugate Therapy in HR+ Metastatic Breast Cancer

Kelly E. McCann, MD

‍

Audience Q&A and Panel Discussion

Michael Danso, MD; Karthik V. Giridhar, MD; Kelly E. McCann, MD